Aspirin Or Warfarin To Prevent Stroke (NCT00004728) | Clinical Trial Compass
TerminatedPhase 3
Aspirin Or Warfarin To Prevent Stroke
United States
Plain-language summary
The purpose of this study is to determine whether aspirin or warfarin is more effective in preventing stroke in patients with intracranial stenosis.
Who can participate
Age range40 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* TIA or non-severe stroke within 90 days prior to randomization (including day 90)
* Modified Rankin score of \< 3
* High grade stenosis (50 to 99 percent) of a major intracranial artery (carotid artery, MCA stem (M1), vertebral artery,and basilar artery) documented by conventional angiography within 90 days prior to randomization (including day 90)
* TIA or stroke is attributed to high grade intracranial stenosis
* Age \> 40 years
* Patient is able to follow an outpatient protocol(requiring monthly blood tests and clinic visits every four months for the duration of the study) and is available by telephone
* Patient understands the purpose and requirements of the study, can make him/herself understood, and has provided informed consent
Exclusion Criteria:
* Extracranial carotid stenosis (\> 50 percent) ipsilateral to stenosis of the intracranial carotid artery or MCA (ie.tandem stenoses, either of which could have caused patient's symptoms)
* Isolated stenosis of the anterior cerebral artery, posterior cerebral artery, MCA division, or a distal branch of the MCA
* Intracranial or extracranial arterial dissection, Moya Moya disease, vasculitis, radiation induced vasculopathy, fibromuscular dysplasia
* Presence of any of the following unequivocal cardiac sources of embolism: chronic or paroxysmal atrial fibrillation, mitral stenosis, mechanical valve, endocarditis, intracardiac clot or vegetation, myocardial infarction within three months, dilated cardio…
Trial details
NCT IDNCT00004728
SponsorNational Institute of Neurological Disorders and Stroke (NINDS)